Skip to main content
Top

Drugs

Issue 11/2018

Content (10 Articles)

The Future of IL-1 Targeting in Kidney Disease

  • Leading Article

Baris Afsar, Adrian Covic, Alberto Ortiz, Rengin Elsurer Afsar, Mehmet Kanbay

New Developments in the Management of Cytomegalovirus Infection After Transplantation

  • Review Article

Atibordee Meesing, Raymund R. Razonable

Assessment of the Risk of Rhabdomyolysis and Myopathy During Concomitant Treatment with Ticagrelor and Statins

  • Open Access
  • Review Article

Dorota Danielak, Marta Karaźniewicz-Łada, Franciszek Główka

Centrally Acting Agents for Obesity: Past, Present, and Future

  • Review Article

Ann A. Coulter, Candida J. Rebello, Frank L. Greenway

Regorafenib: A Review in Metastatic Colorectal Cancer

  • Adis Drug Evaluation

Sohita Dhillon

Vismodegib: A Review in Advanced Basal Cell Carcinoma

  • Adis Drug Evaluation

James E. Frampton, Nicole Basset-Séguin

Erenumab: First Global Approval

  • AdisInsight Report

Anthony Markham

Avatrombopag: First Global Approval

  • AdisInsight Report

Matt Shirley

Correction to: Nonacog Beta Pegol: A Review in Haemophilia B

  • Open Access
  • Correction

Yahiya Y. Syed

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images